GB Meka
Stocks to watch

DXCM

Compare

DEXCOM INC · Healthcare

$86.29
▼ 0.4%Close 2026-09-30

Live intraday price

Compare with our price levels

T292.51
T190.39
E182.29
E369.67
SL67.49

Close 2026-09-30: $86.29 · Levels are calculated once a day from the closing price; live prices come from TradingView (may be delayed at times)

Waiting▲ Leaning positive

Not in the buy zone yet — needs to drop 4.6% · 1 whale recently bought

1 month
▼ 5.2%
3 months
▲ 25.3%
1 year
▲ 29.8%
Analyst target
$94.48 +9.5%

🎯 Trade plan by price level

Buy in 3 tranches in the buy zone · sell in 3 tranches at the targets · sell everything if the stop-loss breaks

Price levels and picks are calculated automatically with the same formula for every stock — for education only, not a recommendation to buy or sell. · How it's calculated

Buy zone
E1$82.29 -4.6%
E2$72.77 -15.7%
E3$69.67 -19.3%
Targets
T1$90.39 4.8%
T2$92.51 7.2%
T3$96.86 12.2%
Stop-loss
SL$67.49 -21.8%
Whale cost ~$69.67 -19.3%

Risk : reward 1 : 2.4Moves ~$2.17 a day

⚖️ Positives and risks

✓ Positives (4)
  • ●1 whale bought or added last quarter
  • ●Long-term uptrend (above a rising MA200)
  • ●Beat the market (S&P 500) by +20% over 6 months
  • ●Most analysts rate it Strong Buy
! Risks (1)
  • ●1 whale sold or trimmed: Joel Greenblatt (trimmed)

🕯️ Price chart

Green lines = buy zone E1–E3 · orange = targets T1–T3 · red = stop-loss · arrows = where the paper-trading bot bought/sold

🐋 Whales holding this stock

From each whale's latest quarterly filing

👔 Insider buying & selling

Latest trades from SEC Form 4 filings

All companies
Sell

AUGUSTINOS NICHOLAS · Director

2026-09-15 · 6,539 shares @ $84.04 · pre-planned sale (10b5-1)

$549,538
Sell

Brown Michael Jon · Officer

2026-09-15 · 1,700 shares @ $84.04 · pre-planned sale (10b5-1)

$142,868
Sell

AUGUSTINOS NICHOLAS · Director

2026-09-14 · 1,550 shares @ $84.02 · pre-planned sale (10b5-1)

$130,231
Sell

Sylvain Jereme M · Officer

2026-09-10 · 3,638 shares @ $83.27 · pre-planned sale (10b5-1)

$302,936
Sell

Stern Sadie · Officer

2026-08-27 · 2,565 shares @ $88.37 · pre-planned sale (10b5-1)

$226,669
Sell

SAYER KEVIN R · Chair · Director

2026-08-20 · 19,308 shares @ $89.71 · pre-planned sale (10b5-1)

$2M
Sell

SAYER KEVIN R · Chair · Director

2026-08-20 · 7,351 shares @ $90.78 · pre-planned sale (10b5-1)

$667,332
Sell

SAYER KEVIN R · Chair · Director

2026-08-20 · 97 shares @ $91.41 · pre-planned sale (10b5-1)

$8,867
Sell

Brown Michael Jon · Officer

2026-08-14 · 1,700 shares @ $91.93 · pre-planned sale (10b5-1)

$156,281
Sell

Heller Bridgette P · Director

2026-08-12 · 1,012 shares @ $88.29 · pre-planned sale (10b5-1)

$89,349
Sell

FOLETTA MARK G · Director

2026-08-03 · 2,000 shares @ $85.32 · pre-planned sale (10b5-1)

$170,640
Sell

FOLETTA MARK G · Director

2026-07-31 · 2,000 shares @ $80.00 · pre-planned sale (10b5-1)

$160,000
Sell

SAYER KEVIN R · Chair · Director

2026-07-20 · 26,756 shares @ $76.32 · pre-planned sale (10b5-1)

$2M
Sell

Brown Michael Jon · Officer

2026-07-15 · 1,700 shares @ $74.42 · pre-planned sale (10b5-1)

$126,514
Sell

SAYER KEVIN R · Chair · Director

2026-07-06 · 26,756 shares @ $72.00 · pre-planned sale (10b5-1)

$2M

📊 Past earnings and price reaction

Actual EPS vs. analyst estimates · the price move on the first trading day after the report and over the next 20 trading days

Post-earnings, all stocks
2026-07-30Beat +15%

Actual EPS $0.70 · est. $0.61 · After close

▲ 12.0%

Day 1

+8.8%

Next 20 days

2026-04-30Beat +19%

Actual EPS $0.56 · est. $0.47 · After close

▲ 3.0%

Day 1

+22.0%

Next 20 days

2026-02-12In line +5%

Actual EPS $0.68 · est. $0.65 · After close

▲ 7.6%

Day 1

-5.3%

Next 20 days

2025-10-30Beat +8%

Actual EPS $0.61 · est. $0.57 · After close

▼ 14.6%

Day 1

+9.1%

Next 20 days

2025-07-30Beat +8%

Actual EPS $0.48 · est. $0.44 · After close

▼ 9.3%

Day 1

-7.0%

Next 20 days

2025-05-01In line -3%

Actual EPS $0.32 · est. $0.33 · After close

▲ 16.2%

Day 1

+4.8%

Next 20 days

2025-02-13Miss -10%

Actual EPS $0.45 · est. $0.50 · After close

▲ 5.9%

Day 1

-19.9%

Next 20 days

2024-10-24In line +4%

Actual EPS $0.45 · est. $0.43 · After close

▼ 1.9%

Day 1

-0.8%

Next 20 days

Listen to the earnings call or read the full report on DXCM's investor relations page ↗ · Earnings data from Yahoo Finance

💬 User reviews

Rate and review this stock (sign-in required) — reviews don't affect the system's scores

Loading…

Ratings and comments are each user's own opinion. They don't affect the Smart-Money Score, signals, or price levels and are not investment advice · The average counts each person's latest rating, one vote per person

📰 Latest news

All news

🔬 Deep dive

For those who want the detailed numbers

Fundamentals
Market cap$32.7B
Next earnings2026-10-29
P/E (price to earnings)34.2
Forward P/E (on expected earnings)27.7
Revenue growth (YoY)+13.1%
Earnings growth (YoY)+43.6%
Net profit margin+20.1%
ROE+38.5%
Debt to equity (D/E)53%
Dividend yield-
Analyst targets (high / low)$115.00 / $79.00
Number of analysts25
Trend and technical indicators
Trend short / mid / longDowntrend ↘ · Uptrend ↗ · Uptrend ↗
RSI47
MA50 / MA200$85.78 / $72.86
Distance from MA200+18.4%
MACDNegative
1-year high / low$92.59 / $54.11
vs. S&P 500 (6 months)+19.5%
Volume vs. average0.84×